ASHLEY PARENT-LEW: Open Payments
NPI 1578028247 · GRAY, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,780 in 92 payments from 20 companies in 2025. Trend: 2023 $1,226 · 2024 $1,794 · 2025 $1,780
Food & beverage: $1,780
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $287 |
| PFIZER INC. | 14 | $268 |
| Novo Nordisk Inc | 12 | $217 |
| AstraZeneca Pharmaceuticals LP | 8 | $202 |
| Lilly USA, LLC | 8 | $135 |
| Corcept Therapeutics | 5 | $93 |
| Amgen Inc. | 5 | $86 |
| Otsuka America Pharmaceutical, Inc. | 4 | $81 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $54 |
| GlaxoSmithKline, LLC. | 3 | $50 |
Products named: VRAYLAR, NURTEC ODT, MOUNJARO, FARXIGA, Wegovy, REXULTI, Korlym, OTEZLA.
Industry payments across GA — which companies pay providers there.
